Stuart Therapeutics, Inc. Announces Upcoming Presentations at ARVO 2023 Annual Meeting

Two ARVO presentations will feature research results from the company’s preclinical research in Corneal Nerve Repair and Myopia STUART, Fla., March 9, 2023 /PRNewswire/ — Stuart Therapeutics, Inc., a clinical-stage ophthalmic biopharmaceutical company focused on developing therapies for…

Leave a Reply

Your email address will not be published. Required fields are marked *